Table:
begin	end	state
1	62	non-cytoplasmic
63	83	transmembrane
84	93	cytoplasmic
94	113	transmembrane
114	118	non-cytoplasmic
119	140	transmembrane
141	163	cytoplasmic
164	184	transmembrane
185	194	non-cytoplasmic
195	214	transmembrane
215	250	cytoplasmic
251	270	transmembrane
271	289	non-cytoplasmic
290	310	transmembrane
311	318	cytoplasmic
319	338	transmembrane
339	344	non-cytoplasmic
345	368	transmembrane
369	378	cytoplasmic
379	401	transmembrane
402	412	non-cytoplasmic
413	432	transmembrane
433	445	cytoplasmic

Input:
>WP_057507967.1 NCBI__GCF_001431535.1:WP_057507967.1
MSISQSTAASPVSERAALKRSVSNTLKGSAGNLVEWYDVYVYSVFAKYFESQFFSADDKN
STMYIWGIFAATFLMRPIGAWYFGRFADRYGRRLALTVSVSVMAACSFLIAIAPTAASIG
IWAAVILLFARLLQGFATGGEYGASATYMSEAAVPGWRGFLSSFHYVTLVGGHVLAQAVL
LVMLLSWDTSHVSEWGWRVAFGIGGIGALVVFWLRRTMDESLSAESIEAAKDGKAKASGS
MRELFVNQWRPLLLCFLITAGGTVAFYTYTINGPKMIQTAFAGDDVITGTWINLGVLTFL
MLLQPLGGLLSDRIGRKSLLVFFGVGGVLYTWYLVTALPQQTSALSAFLILATGFVILTG
YTSINAVVKAELFPAHIRALGVGLGYALANSLFGGTAPLLYQGALKAGRVDEFVIYITAV
IAVSLVVYIFFLKNKGPNWLDGTRK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server